Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $789.3600 (-0.81%) ($789.3600 - $789.3600) on Tue. Apr. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.56% (three month average) | RSI | 29 | Latest Price | $789.3600(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(47%) DIA(35%) VYM(33%) IWD(32%) | Factors Impacting REGN price | REGN will decline at least -0.78% in a week (0% probabilities). VXX(-29%) VIXM(-22%) TBT(-4%) UUP(-3%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.78% (StdDev 1.56%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $815.56 | 5 Day Moving Average | $798.52(-1.15%) | 10 Day Moving Average | $809.3(-2.46%) | 20 Day Moving Average | $815.56(-3.21%) | To recent high | -4.9% | To recent low | 7.2% | Market Cap | $83.695b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |